Oaktree Acquisition Corp. III Life Sciences - OACC - Fundamentals

Feel free to try out our engine!Whenever you're ready, pick a plan!

‌
‌

‌

Let's get started...

‌

Breakdown	2024 12/31	2025 12/31	TTM
REVENUE	0	0	--	📊
Revenue Growth (1Y)	--	--	--	📊
Revenue Growth (5Y)	--	--	--	📊
Revenue Growth (10Y)	--	--	--	📊
Cost of Revenue	0	0	--	📊
Cost of Revenue Growth (1Y)	--	--	--	📊
Cost of Revenue Growth (5Y)	--	--	--	📊
Cost of Revenue Growth (10Y)	--	--	--	📊
Gross Profit	0	0	--	📊
Gross Profit Growth (1Y)	--	--	--	📊
Gross Profit Growth (5Y)	--	--	--	📊
Gross Profit Growth (10Y)	--	--	--	📊
Operating Expenses	0	1	1	📊
Operating Expenses Growth (1Y)	--	+169835.56%	--	📊
Operating Expenses Growth (5Y)	--	--	--	📊
Operating Expenses Growth (10Y)	--	--	--	📊
Sell General Administrative	0	1	1	📊
Research and Development	0	0	--	📊
Other Income Expenses	0	0	--	📊
EBITDA	0	-1	-1	📊
EBITDA Growth (1Y)	--	--	--	📊
EBITDA Growth (5Y)	--	--	--	📊
EBITDA Growth (10Y)	--	--	--	📊
Depreciation and Amortization	0	0	--	📊
Operating Income	-0	-1	-1	📊
Operating Income Growth (1Y)	--	-169835.56%	--	📊
Operating Income Growth (5Y)	--	--	--	📊
Operating Income Growth (10Y)	--	--	--	📊
Interest Expense	0	0	--	📊
Pre Tax Income	0	7	7	📊
Tax Provision	0	0	--	📊
NET INCOME	0	7	7	📊
Net Income Growth (1Y)	--	+273564.70%	--	📊
Net Income Growth (5Y)	--	--	--	📊
Net Income Growth (10Y)	--	--	--	📊
Basic EPS	0.23	0.3	67.71	📊
Diluted EPS	0	0.3	67.71	📊
Basic Average Shares	0	19	17	📊
Diluted Average Shares	0	19	17	📊

Breakdown	2024 12/31	2025 12/31	TTM
REVENUE	0	0	--	📊
Revenue Growth (1Y)	--	--	--	📊
Revenue Growth (5Y)	--	--	--	📊
Revenue Growth (10Y)	--	--	--	📊
Cost of Revenue	0	0	--	📊
Cost of Revenue Growth (1Y)	--	--	--	📊
Cost of Revenue Growth (5Y)	--	--	--	📊
Cost of Revenue Growth (10Y)	--	--	--	📊
Gross Profit	0	0	--	📊
Gross Profit Growth (1Y)	--	--	--	📊
Gross Profit Growth (5Y)	--	--	--	📊
Gross Profit Growth (10Y)	--	--	--	📊
Operating Expenses	0	1	1	📊
Operating Expenses Growth (1Y)	--	+169835.56%	--	📊
Operating Expenses Growth (5Y)	--	--	--	📊
Operating Expenses Growth (10Y)	--	--	--	📊
Sell General Administrative	0	1	1	📊
Research and Development	0	0	--	📊
Other Income Expenses	0	0	--	📊
EBITDA	0	-1	-1	📊
EBITDA Growth (1Y)	--	--	--	📊
EBITDA Growth (5Y)	--	--	--	📊
EBITDA Growth (10Y)	--	--	--	📊
Depreciation and Amortization	0	0	--	📊
Operating Income	-0	-1	-1	📊
Operating Income Growth (1Y)	--	-169835.56%	--	📊
Operating Income Growth (5Y)	--	--	--	📊
Operating Income Growth (10Y)	--	--	--	📊
Interest Expense	0	0	--	📊
Pre Tax Income	0	7	7	📊
Tax Provision	0	0	--	📊
NET INCOME	0	7	7	📊
Net Income Growth (1Y)	--	+273564.70%	--	📊
Net Income Growth (5Y)	--	--	--	📊
Net Income Growth (10Y)	--	--	--	📊
Basic EPS	0.23	0.3	67.71	📊
Diluted EPS	0	0.3	67.71	📊
Basic Average Shares	0	19	17	📊
Diluted Average Shares	0	19	17	📊

Oaktree Acquisition Corp. III Life Sciences - OACC - Fundamentals - Financial Statements